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Background: Nontuberculous mycobacteria (NTM) infection is an emerging, but neglected public health concern
in China.
Findings: To investigate diagnostic delay of NTM diseases in China, we analyzed 91 patients with pulmonary NTM
infection in ShandongProvince. The median diagnostic delay time of the analyzed patients was 84 days, which was
significantly associated with rural inhabitance (135 days vs. 73 days of urban inhabitance, p < 0.01) and lower level
of first visiting hospitals/clinics (70 and 82 days of tertiary and secondary hospitals/clinics respectively vs. 120 days
of primary hospitals/clinics, p < 0.05). M. farcinogenes was isolated from a 79-year-old male patient, which is the first
report of pulmonary infection in humans.
Conclusions: Our results indicate a significant diagnostic delay of NTM diseases in China, especially for rural
patients with limited access to higher-level healthcare services.
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Nontuberculous mycobacteria (NTM) diseases have
been neglected in most of developing world [1]. With
the global pandemic of HIV/AIDS and aging population,
NTM have been increasingly associated with pulmonary
diseases in humans [2]. In China, Mycobacterium tuber-
culosis (MTB) still causes the majority of pulmonary
mycobacteria diseases. Nevertheless, in the last decade,
the NTM isolation rate has shown an increasing trend
in China [3,4]. Pulmonary NTM diseases may share cli-
nical signs with TB, causing a clinical dilemma in early
diagnosis and treatment. Delay or misdiagnosis of NTM
diseases may worsen the disease and increase the mor-
tality and economic burden of patients. In this study, we
retrospectively investigated the diagnostic history and
clinical characteristics of patients with pulmonary NTM* Correspondence: mx79@hotmail.com
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diagnostic delay in China.
Study population and methods
This study was conducted in Shandong Province, which is
the second largest province in China (population size, 96
million and 59% rural) and has approximately 40,000 new
TB cases annually. Shandong Provincial Chest Hospital
(SPCH) is the only provincial-level hospital specialized in
TB (a referral hospital) and other lung infections, and net-
works 139 county/city-level TB clinics. Between January 1,
2007 and December 31, 2012, 91 patients were diagnosed
with pulmonary NTM disease based on the American
Thoracic Society/Infectious Disease Society of America
(ATS) diagnostic criteria [5]. Multiple (≥ = 2) sputum
specimens from each patient were collected for Acid Fast
Bacillus (AFB) test and mycobacterial culture at SPCH.
Identification of mycobacteria species was first carried out
at the ISO15189-certified SPCH TB reference laboratory
by conventional biochemical tests, P-nitrobenzoic acid
(PNB) and 2-Thiophene carboxylic acid hydrazide (TCH)
testing following a standard protocol [6], and further. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ID Microbial Indentification Software V2.0, PE Applied
Biosystems) at the species level as previously described
[7]. To minimize possible species identification error,
DNA extraction and 16S rRNA gene sequencing of
each NTM isolate was independently conducted twice.
Statistical analysis was carried out by using SPSS (IBM,
USA). The study protocol was approved by the SPCH In-
stitutional Review Board.
Results
Over the six study years, a total of 91 patients (mean
age ± SD, 45.7 ± 16.2 years; age range, 15 – 79 years;
male, 73.6%) were identified with pulmonary NTM in-
fection from 4541 patients with positive mycobacteria
cultures at SPCH, indicating an overall NTM isolation
rate of 2.0% among all mycobacterial isolates, that did
not show a significantly increasing or decreasing trend
within the study period. The patients were predomin-
antly male (73.6%) and adult (98.9% older than 18 years;
and 37.4% from age group of 46–64 years) (Table 1).
The diagnostic delay of NTM patients was defined as
the period from the date of the patient's first visit at the
healthcare service to the date of diagnosis. Median diag-
nostic delay time for the 91 NTM patients was 84 days
(range, 28 – 1,144 days), and it was not significantly
associated with sex and age of NTM patients (Table 1).
Patients living in rural areas showed a significantly lon-
ger diagnostic delay time than those in the urban areasTable 1 Characteristics and diagnostic delay of 91 NTM
patients






Male 67 (73.6) 86
Female 24 (26.4) 77 0.86
Age (years)
1-17 1 (1.1) 101
18-25 19 (20.9) 66
26-45 23 (25.3) 81
46-65 34 (37.4) 91
>65 14 (15.3) 99 0.71
Inhabited areas
Urban 61 (67.0) 73
Rural 30 (33.0) 135 <0.01
First visiting hospitals/clinics
Tertiary 45 (49.5) 70
Secondary 20 (22.0) 82
Primary 26 (28.5) 120 <0.05(135 vs. 73 days, p < 0.01). Patients with a first visit at
tertiary and secondary hospitals/clinics had significantly
shorter delay time than those at primary hospitals/clinics
(70 and 82 days respectively vs. 120 days, p < 0.05)
(Table 1).
All 91 NTM patients were HIV seronegative. Other
comorbidities included diabetes (9.9%), cardiovascular
diseases (13.2%), chronic obstructive pulmonary disease
(COPD, 12.1%), and bronchiectasis (20.9%) (Table 2).
Mycobacterium (M.) intracellulare infection accounted for
46.1% of these NTM diseases, following by M. chelonae-
abscessus complex (28.6%), M. kansasii (12.1%), M. gordo-
nae (5.5%), M. fortuitum (5.5%), M. asiaticum (1.1%), and
M. farcinogenes (1.1%). In this study, a 79-year-old male
patient was diagnosed with severe COPD, bronchiectasis,
and pulmonary infection Positive results were shown in
six consecutive sputum AFB smear tests. Mycobacterial
culture and identification revealed isolation of M. farcino-
genes. It is the second report of human infection and
the first report of pulmonary M. farcinogenes disease in
humans [8].
Discussion
Our data suggest that the diagnosis of pulmonary NTM
disease is significantly delayed in China, which is attributed
to rural inhabitance, and limited access to higher-level
healthcare and laboratory services (tertiary and secondary).
In China, approximately 71.3% of patients with active TB
live in the resource-poor rural areas, where the mycobac-
teria culture and species identification tests are not routine
testing for each TB or NTM suspect yet [8]. In our previ-
ous studies in Shandong, without species identification
testing, NTM disease was often misdiagnosed as multi-
drug resistant TB (MDR-TB) and accounted for 30.7% of
reported MDR-TB (due to natural resistance of NTM to
anti-TB drugs) [4]. Approximately 4% of retreated TB cases
were caused by NTM infections [4]. The 2010 Chinese
National TB Surveillance Program has reported a NTM
isolation rate of 22.9% among 363 culture positive TB sus-
pects [9]. This data strongly indicates that NTM infection
has become a significant public health concern in China,
which should not be neglected in disease control practice.
The clinicians and public health professionals in primary
care settings need to improve their awareness of this emer-
ging disease. Mycobacteria culture and species identifica-
tion tests need to be routine testing for each TB or NTM
suspect.
This study is a hospital-based surveillance study with a
limited sample size, which aims to investigate the diag-
nostic delay caused by the healthcare system. There are
definitely some other factors, such as patients’ comorbid
diseases and environmental risks [10], also contributing
to the delay of care, which need to be investigated in
future studies.
Table 2 Clinical characteristics of patients infected with different NTM species
M. intracellulare M. chelonae/abscessus complex M. kansasii M. gordonae M. fortuitum M. asiaticum M. farcinogenes Total
N (%) 42 (46.1) 26 (28.6) 11 (12.1) 5 (5.5) 5 (5.5) 1 (1.1) 1 (1.1) 91 (100.0)
Symptoms
Chest pain/distress 10 (23.8) 14 (53.8) 1 (9.1) 0 (0.0) 2 (40.0) 1 (100.0) 0 (0.0) 28 (30.8)
Cough 36 (85.7) 18 (69.2) 9 (81.8) 4 (80.0) 4 (80.0) 0 (0.0) 1 (100.0) 72 (79.1)
Hemoptysis 8 (19.0) 6 (23.1) 6 (54.5) 2 (40.0) 1 (20.0) 0 (0.0) 0 (0.0) 23 (25.3)
Fever/Sweats 21 (50.0) 16 (61.5) 1 (9.1) 1 (20.0) 1 (20.0) 0 (0.0) 1 (100.0) 41 (45.1)
Comorbidities
Comorbid conditions
Diabetes 4 (9.5) 2 (7.7) 1 (9.1) 1 (20.0) 1 (20.0) 0 (0.0) 0 (0.0) 9 (9.9)
Cardiac disease 6 (14.3) 0 (0.0) 2 (18.2) 2 (40.0) 2 (40.0) 0 (0.0) 0 (0.0) 12 (13.2)
COPD 8 (19.0) 2 (7.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100.0) 11 (12.1)
Bronchiectasis 11 (26.2) 5 (19.2) 0 (0.0) 0 (0.0) 1 (20.0) 1 (100.0) 1 (100.0) 19 (20.9)
Chest Radiography
Location in lung
Bilateral 36 (85.7) 19 (73.1) 9 (81.8) 3 (60.0) 3 (60.0) 1 (100.0) 1 (100.0) 72 (79.1)
Simply left lung 2 (4.8) 2 (7.7) 1 (9.1) 1 (20.0) 1 (20.0) 0 (0.0) 0 (0.0) 7 (7.7)
Simply right lung 4 (9.5) 5 (19.2) 1 (9.1) 1 (20.0) 1 (20.0) 0 (0.0) 0 (0.0) 12 (13.2)
Diffuse lung (up and lower lobes) 20 (47.6) 13 (50.0) 4 (36.4) 1 (20.0) 3 (60.0) 0 (0.0) 0 (0.0) 41 (45.1)
Infiltrates 36 (85.7) 21 (80.8) 8 (72.7) 4 (80.0) 5 (100) 0 (0.0) 1 (100.0) 75 (82.4)
Cavitation 28 (66.7) 8 (30.8) 10 (90.9) 2 (40.0) 3 (60.0) 1 (100.0) 1 (100.0) 53 (58.2)
Nodules 30 (71.4) 18 (69.2) 11 (100) 3 (60.0) 4 (80.0) 1 (100.0) 0 (0.0) 67 (73.6)
Miliary pattern 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Consolidation 11(26.2) 4 (15.4) 1 (9.1) 0 (0.0) 1 (20.0) 0 (0.0) 1 (100.0) 18 (19.8)
Pleural effusion 4 (9.5) 5 (19.2) 0 (0.0) 0 (0.0) 2 (40.0) 0 (0.0) 1 (100.0) 12 (13.2)
Pleural thickness 11 (26.2) 8 (30.8) 3 (27.3) 0 (0.0) 1 (20.0) 1 (100.0) 0 (0.0) 24 (26.4)
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